Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frontier Technology Corporation (FTC) is a specialized manufacturer of Californium-252 (Cf-252) neutron sources and customized shielding equipment. Based in Xenia, Ohio, the company is a global leader in providing high-output neutron sources for industrial, research, and medical applications. In the healthcare sector, FTC's Cf-252 sources are utilized in neutron brachytherapy for the treatment of various cancers, including cervical and prostate malignancies. The company provides comprehensive services including source design, fabrication, and the supply of Type A and Type B shipping containers. FTC is one of the few commercial facilities in the world capable of handling and encapsulating this rare isotope for specialized radiation therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frontier Technology Corporation.